Åke Ellin
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Eicosanoids and Hypertension Pharmacology 5
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Sten Orrenius (6 shared papers)Birgitta Strandvik (4 shared papers)Sten V. Jakobsson (2 shared papers)John B. Schenkman (2 shared papers)Hans Gilljam (2 shared papers)Åke Pilotti (1 shared paper)Carl‐Gunnar Swahn (1 shared paper)Agneta Löf (1 shared paper)
- Journals
- Scandinavian Journal of Clinical and Laboratory Investigation (3 papers)Archives of Biochemistry and Biophysics (3 papers)FEBS Letters (1 paper)Chemico-Biological Interactions (1 paper)Drug Metabolism and Disposition (1 paper)
- Partner nations
- Sweden
In The Last Decade
Åke Ellin
13 papers receiving 475 citations
Peers
Comparison fields: 5 of 77
- Pharmacology 251
- Biochemistry 139
- Clinical Biochemistry 71
- Emergency Medicine 30
- Pharmacology 52
Countries citing papers authored by Åke Ellin
This map shows the geographic impact of Åke Ellin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åke Ellin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åke Ellin more than expected).
Fields of papers citing papers by Åke Ellin
This network shows the impact of papers produced by Åke Ellin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åke Ellin. The network helps show where Åke Ellin may publish in the future.
Co-authors
The 18 scholars most cited alongside Åke Ellin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 99 | |
| 2 | 1989 | 64 | |
| 3 | 1973 | 62 | |
| 4 | 1975 | 57 | |
| 5 | 1980 | 57 | |
| 6 | 1973 | 56 | |
| 7 | 1986 | 42 | |
| 8 | 1975 | 40 | |
| 9 | 1988 | 23 | |
| 10 | 1972 | 9 | |
| 11 | 1971 | 8 | |
| 12 | 1994 | 2 | |
| 13 | Fatty acid hydroxylation in rat kidney and liver microsomes | 1975 | 1 |
About Åke Ellin
Åke Ellin is a scholar working on Biochemistry, Pharmacology, Clinical Biochemistry, Pulmonary and Respiratory Medicine and Oncology, having authored 13 papers that have together received 520 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Metabolism and Genetic Disorders (4 papers), Cystic Fibrosis Research Advances (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Asthma and respiratory diseases (2 papers), Advanced Chemical Sensor Technologies (1 paper) and Poisoning and overdose treatments (1 paper). The work is most often cited by research in Pharmacology (251 citations), Biochemistry (139 citations), Clinical Biochemistry (71 citations), Emergency Medicine (30 citations) and Pharmacology (52 citations). Åke Ellin has collaborated with scholars based in Sweden. Frequent co-authors include Sten Orrenius, Birgitta Strandvik, Sten V. Jakobsson, John B. Schenkman, Hans Gilljam, Åke Pilotti, Carl‐Gunnar Swahn, Agneta Löf, Rolf Blomstrand and Lars-Gösta Wiman. Their work appears in journals such as Scandinavian Journal of Clinical and Laboratory Investigation, Archives of Biochemistry and Biophysics, FEBS Letters, Chemico-Biological Interactions and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.